TNFRSF8 and primary cutaneous T-cell non-Hodgkin lymphoma: Moderate-Dose Local Radiotherapy in Symptomatic CD30-Positive, Anaplastic Lymphoma Kinase (ALK)-Negative Primary Cutaneous T-cell Lymphoma.